These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33542970)

  • 1. Acquired CARD11 mutation promotes BCR independence in Diffuse Large B Cell Lymphoma.
    Caeser R; Walker I; Gao J; Shah N; Rasso-Barnett L; Anand S; Martin JE; Hodson DJ
    JCO Precis Oncol; 2021; 5():145-152. PubMed ID: 33542970
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphomagenic CARD11/BCL10/MALT1 signaling drives malignant B-cell proliferation via cooperative NF-κB and JNK activation.
    Knies N; Alankus B; Weilemann A; Tzankov A; Brunner K; Ruff T; Kremer M; Keller UB; Lenz G; Ruland J
    Proc Natl Acad Sci U S A; 2015 Dec; 112(52):E7230-8. PubMed ID: 26668357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.
    Takeuchi T; Yamaguchi M; Kobayashi K; Miyazaki K; Tawara I; Imai H; Ono R; Nosaka T; Tanaka K; Katayama N
    Cancer; 2017 Apr; 123(7):1166-1173. PubMed ID: 27915469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of nuclear factor-κB regulators TNFAIP3 and CARD11 in Middle Eastern diffuse large B-cell lymphoma.
    Bu R; Bavi P; Abubaker J; Jehan Z; Al-Haqawi W; Ajarim D; Al-Dayel F; Uddin S; Al-Kuraya KS
    Leuk Lymphoma; 2012 Oct; 53(10):1971-7. PubMed ID: 22397314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma.
    Lenz G; Davis RE; Ngo VN; Lam L; George TC; Wright GW; Dave SS; Zhao H; Xu W; Rosenwald A; Ott G; Muller-Hermelink HK; Gascoyne RD; Connors JM; Rimsza LM; Campo E; Jaffe ES; Delabie J; Smeland EB; Fisher RI; Chan WC; Staudt LM
    Science; 2008 Mar; 319(5870):1676-9. PubMed ID: 18323416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A20, ABIN-1/2, and CARD11 mutations and their prognostic value in gastrointestinal diffuse large B-cell lymphoma.
    Dong G; Chanudet E; Zeng N; Appert A; Chen YW; Au WY; Hamoudi RA; Watkins AJ; Ye H; Liu H; Gao Z; Chuang SS; Srivastava G; Du MQ
    Clin Cancer Res; 2011 Mar; 17(6):1440-51. PubMed ID: 21266526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramolecular Interactions and Regulation of Cofactor Binding by the Four Repressive Elements in the Caspase Recruitment Domain-containing Protein 11 (CARD11) Inhibitory Domain.
    Jattani RP; Tritapoe JM; Pomerantz JL
    J Biol Chem; 2016 Apr; 291(16):8338-48. PubMed ID: 26884334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.
    Davis RE; Ngo VN; Lenz G; Tolar P; Young RM; Romesser PB; Kohlhammer H; Lamy L; Zhao H; Yang Y; Xu W; Shaffer AL; Wright G; Xiao W; Powell J; Jiang JK; Thomas CJ; Rosenwald A; Ott G; Muller-Hermelink HK; Gascoyne RD; Connors JM; Johnson NA; Rimsza LM; Campo E; Jaffe ES; Wilson WH; Delabie J; Smeland EB; Fisher RI; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Pierce SK; Staudt LM
    Nature; 2010 Jan; 463(7277):88-92. PubMed ID: 20054396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic CARD11 mutations induce hyperactive signaling by disrupting autoinhibition by the PKC-responsive inhibitory domain.
    Lamason RL; McCully RR; Lew SM; Pomerantz JL
    Biochemistry; 2010 Sep; 49(38):8240-50. PubMed ID: 20799731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CARD11 gain of function upregulates BCL2A1 expression and promotes resistance to targeted therapies combination in B-cell lymphoma.
    Decombis S; Bellanger C; Le Bris Y; Madiot C; Jardine J; Santos JC; Boulet D; Dousset C; Menard A; Kervoelen C; Douillard E; Moreau P; Minvielle S; Moreau-Aubry A; Tessoulin B; Roue G; Bidère N; Le Gouill S; Pellat-Deceunynck C; Chiron D
    Blood; 2023 Nov; 142(18):1543-1555. PubMed ID: 37562004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of the B-Cell Receptor Pathway Confer Chemoresistance in Primary Cutaneous Diffuse Large B-Cell Lymphoma Leg Type.
    Ducharme O; Beylot-Barry M; Pham-Ledard A; Bohers E; Viailly PJ; Bandres T; Faur N; Frison E; Vergier B; Jardin F; Merlio JP; Gros A
    J Invest Dermatol; 2019 Nov; 139(11):2334-2342.e8. PubMed ID: 31150604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYD88, CARD11, and CD79B Oncogenic Mutations are Rare Events in the Indian Cohort of De Novo Nodal Diffuse Large B-Cell Lymphoma.
    Aggarwal V; Das A; Bal A; Srinivasan R; Das R; Prakash G; Malhotra P; Varma S
    Appl Immunohistochem Mol Morphol; 2019 Apr; 27(4):311-318. PubMed ID: 29734251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperative Control of Caspase Recruitment Domain-containing Protein 11 (CARD11) Signaling by an Unusual Array of Redundant Repressive Elements.
    Jattani RP; Tritapoe JM; Pomerantz JL
    J Biol Chem; 2016 Apr; 291(16):8324-36. PubMed ID: 26884335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CARMA1 and chromosomal translocations in extranodal marginal zone B-cell lymphomas of MALT type or diffuse large B-cell lymphomas.
    Adam P; Haralambieva E; Greiner A; Ott M; Rosenwald A; Ott G
    Haematologica; 2006 Nov; 91(11):1575-6. PubMed ID: 17043017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting CARD11 translation during BCR activation by targeting the eIF4A RNA helicase.
    Steinhardt JJ; Peroutka RJ; Mazan-Mamczarz K; Chen Q; Houng S; Robles C; Barth RN; DuBose J; Bruns B; Tesoriero R; Stein D; Fang R; Hanna N; Pasley J; Rodriguez C; Kligman MD; Bradley M; Rabin J; Shackelford S; Dai B; Landon AL; Scalea T; Livak F; Gartenhaus RB
    Blood; 2014 Dec; 124(25):3758-67. PubMed ID: 25320244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression and prognostic value of CARD11 in diffuse large B cell lymphoma].
    Zhao D; Li D; Zhong D; Zhang W
    Zhonghua Xue Ye Xue Za Zhi; 2016 Jan; 37(1):30-4. PubMed ID: 26876250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting a Novel G-Quadruplex in the
    Swafford K; Acharya B; Xu YZ; Raney T; McCrury M; Saha D; Frett B; Kendrick S
    Genes (Basel); 2022 Jun; 13(7):. PubMed ID: 35885931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas.
    Reimann M; Schrezenmeier J; Richter-Pechanska P; Dolnik A; Hick TP; Schleich K; Cai X; Fan DNY; Lohneis P; Maßwig S; Denker S; Busse A; Knittel G; Flümann R; Childs D; Childs L; Gätjens-Sanchez AM; Bullinger L; Rosenwald A; Reinhardt HC; Schmitt CA
    Blood; 2021 May; 137(20):2785-2799. PubMed ID: 33232972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of targetable oncogenic mutations and genomic alterations in Epstein-Barr virus-associated diffuse large B-cell lymphoma of the elderly.
    Gebauer N; Gebauer J; Hardel TT; Bernard V; Biersack H; Lehnert H; Rades D; Feller AC; Thorns C
    Leuk Lymphoma; 2015 Apr; 56(4):1100-6. PubMed ID: 25030036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of Regulated and Dysregulated CARD11 Signaling in Adaptive Immunity and Disease.
    Bedsaul JR; Carter NM; Deibel KE; Hutcherson SM; Jones TA; Wang Z; Yang C; Yang YK; Pomerantz JL
    Front Immunol; 2018; 9():2105. PubMed ID: 30283447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.